T-lymphocytes/NNS
from/IN
individuals/NNS
with/IN
filarial/JJ
inflammatory/JJ
disease/NN
have/VBP
increased/VBN
transendothelial/JJ
migration/NN
in/FW
vitro/FW
./.

The/DT
in/FW
vitro/FW
transendothelial/JJ
migration/NN
of/IN
circulating/VBG
filarial/JJ
antigen-specific/JJ
T-cells/NNS
was/VBD
examined/VBN
in/IN
Wuchereria/FW
banerofti/FW
infection/NN
./.
=====
Circulating/VBG
T-cells/NNS
from/IN
individuals/NNS
with/IN
filaria-induced/JJ
lymphatic/JJ
pathology/NN
(/(
LP/NN
)/)
had/VBD
significantly/RB
greater/JJR
migration/NN
through/IN
unstimulated/JJ
HUVEC/NN
monolayers/NNS
than/IN
did/VBD
T-cells/NNS
from/IN
asymptomatic/JJ
infected/JJ
(/(
MF/NN
)/)
individuals/NNS
(/(
P/NN
=/JJ
0.04/CD
)/)
./.
=====
In/IN
contrast/NN
to/TO
the/DT
MF/NN
individuals/NNS
where/WRB
no/DT
effect/NN
was/VBD
seen/VBN
,/,
transendothelial/JJ
migration/NN
of/IN
48-hr/JJ
filarial/JJ
antigen/NN
stimulated/JJ
T-cells/NNS
from/IN
LP/NN
individuals/NNS
was/VBD
significantly/RB
(/(
P/NN
=/JJ
0.01/CD
)/)
greater/JJR
than/IN
migration/NN
of/IN
48-hr/JJ
media-stimulated/JJ
T-cells/NNS
./.
=====
In/IN
six/CD
of/IN
seven/CD
patients/NNS
examined/VBN
,/,
inhibition/NN
of/IN
the/DT
VLA-4/VCAM-1/NN
pathway/NN
resulted/VBD
in/IN
greater/JJR
than/IN
50/CD
%/NN
inhibition/NN
of/IN
transendothelial/JJ
migration/NN
of/IN
T-cells/NNS
./.